[Flow cytometric DNA analysis in colorectal cancer]. 1989

Y Ando, and A Tsuchiya, and K Sekikawa, and Y Ishii, and T Yoshida, and I Kimijima, and R Abe
Department of Surgery II, Fukushima Medical College, Japan.

Flow cytometric DNA analysis for assessing malignant potential of colorectal carcinoma was investigated by paraffin-embedded materials. Preservation time of paraffin blocks and formalin fixation time of surgical specimens within 14 days do not influence the nuclear DNA content. There was seen a good correlation between the DNA contents of paraffin-embedded and fresh materials obtained from the same surgical specimens. Using deparaffinized tumor specimens, the nuclear DNA content was measured by flow cytometry in 144 patients with primary colorectal cancer, who had been treated from 1971 to 1985. Forty-four percent of colorectal cancer were diploid and 56% were aneuploid. There was no significant correlation between ploidy pattern and clinicopathological factors. However, the patients with aneuploid tumor had a significantly worse survival than those with diploid tumor (Generalized Wilcoxon test, p less than 0.001). The patients with aneuploid seemed to have an unfavorable survival than those with diploid in the same stage, and had a significantly worse survival in each group of negative nodes, P0 and H0. It is concluded, therefore, that the nuclear DNA content of colorectal cancer may be an important prognostic factor, being independent of pathological stage.

UI MeSH Term Description Entries
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011003 Ploidies The degree of replication of the chromosome set in the karyotype. Ploidy
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015179 Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. Colorectal Cancer,Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Cancer, Colorectal,Cancers, Colorectal,Carcinoma, Colorectal,Carcinomas, Colorectal,Colorectal Cancers,Colorectal Carcinomas,Colorectal Neoplasm,Colorectal Tumor,Neoplasm, Colorectal,Tumor, Colorectal,Tumors, Colorectal

Related Publications

Y Ando, and A Tsuchiya, and K Sekikawa, and Y Ishii, and T Yoshida, and I Kimijima, and R Abe
March 1988, The Australian and New Zealand journal of surgery,
Y Ando, and A Tsuchiya, and K Sekikawa, and Y Ishii, and T Yoshida, and I Kimijima, and R Abe
November 1990, Nihon Geka Gakkai zasshi,
Y Ando, and A Tsuchiya, and K Sekikawa, and Y Ishii, and T Yoshida, and I Kimijima, and R Abe
July 1994, American journal of surgery,
Y Ando, and A Tsuchiya, and K Sekikawa, and Y Ishii, and T Yoshida, and I Kimijima, and R Abe
February 1998, Analytical and quantitative cytology and histology,
Y Ando, and A Tsuchiya, and K Sekikawa, and Y Ishii, and T Yoshida, and I Kimijima, and R Abe
January 2002, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology,
Y Ando, and A Tsuchiya, and K Sekikawa, and Y Ishii, and T Yoshida, and I Kimijima, and R Abe
September 1988, The Japanese journal of surgery,
Y Ando, and A Tsuchiya, and K Sekikawa, and Y Ishii, and T Yoshida, and I Kimijima, and R Abe
January 1989, Bulletin du cancer,
Y Ando, and A Tsuchiya, and K Sekikawa, and Y Ishii, and T Yoshida, and I Kimijima, and R Abe
January 1992, Diseases of the colon and rectum,
Y Ando, and A Tsuchiya, and K Sekikawa, and Y Ishii, and T Yoshida, and I Kimijima, and R Abe
May 1994, Gan to kagaku ryoho. Cancer & chemotherapy,
Y Ando, and A Tsuchiya, and K Sekikawa, and Y Ishii, and T Yoshida, and I Kimijima, and R Abe
April 1993, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!